Your browser doesn't support javascript.
loading
Exploring the CXCR4/CXCR7/CXCL12 Axis in Primary Desmoid Tumors.
Baccalini, Edoardo Andrea; Renne, Salvatore Lorenzo; Colombo, Piergiuseppe; Pasqualini, Fabio; Quagliuolo, Vittorio Lorenzo; Cananzi, Ferdinando Carlo Maria; Grizzi, Fabio; Borroni, Elena Monica.
Afiliação
  • Baccalini EA; Sarcoma, Melanoma and Rare Tumors Surgery Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, 20089, Italy.
  • Renne SL; Department of Pathology, IRCCS Humanitas Research Hospital, Rozzano, Milan, 20089, Italy.
  • Colombo P; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, 20090, Italy.
  • Pasqualini F; Department of Pathology, IRCCS Humanitas Research Hospital, Rozzano, Milan, 20089, Italy.
  • Quagliuolo VL; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, 20090, Italy.
  • Cananzi FCM; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, 20090, Italy.
  • Grizzi F; Department of Immunology and Inflammation, IRCCS Humanitas Research Hospital, Rozzano, Milan, 20089, Italy.
  • Borroni EM; Sarcoma, Melanoma and Rare Tumors Surgery Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, 20089, Italy.
Anticancer Agents Med Chem ; 23(20): 2248-2253, 2023.
Article em En | MEDLINE | ID: mdl-36748819
ABSTRACT

BACKGROUND:

Desmoid tumors have an extremely variable natural history. The uncertainty behind desmoid behavior reflects the complexity, which subtends its development and non-linear advancement. Apart from Wnt- ßcatenin mutation, estrogen receptors, and COX-2 overexpression, little is known about the ability of desmoids to grow and recur while being unable to metastasize. Several tumors have been shown to express the CXCR4/CXCR7/CXCL12 axis, whose functions are essential for tumoral development.

AIMS:

This study aimed to investigate the expression of the CXCR4/CXCR7/CXCL12 axis in primary desmoid tumors and discuss the potential role of this key-signaling as an antiangiogenic therapeutic strategy.

METHODS:

In this study, 3 µm-thick consecutive sections from each formalin-fixed and paraffin-embedded tissue block were treated with mouse monoclonal antibodies developed against CD34, CXCR4, CXCR7, and CXCL12.

RESULTS:

Two distinct vessel populations CXCR4+ and CXCR4- vessels, have been found. Similarly, chemokine receptor CXCR7 expression in the entire desmoid tumor series positively stained a portion of tumor-associated vessels, identifying two distinct subpopulations of vessels CXCR7+ and CXCR7- vessels. All 8 neoplastic tissue samples expressed CXCL12. Immunohistochemical positivity was identified in both stromal and endothelial vascular cells. Compared to CXCR4 and CXCR7, the vast majority of tumor-associated vessels were found to express this chemokine.

CONCLUSION:

It is the first time, as per our knowledge, that CXCR4/CXCR7/CXCL12 axis expression has been identified in a desmoid type-fibromatosis series. CXCL12 expression by neoplastic cells, together with CXCR4 and CXCR7 expression by a subgroup of tumor-associated vessels, was detected in all desmoid tumor tissue samples examined. Since chemokines are known contributors to neovascularization, CXCR4/CXCR7/CXCL12 axis may play a role in angiogenesis in this soft-tissue tumor histotype, thereby supporting its growth.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibromatose Agressiva / Receptores CXCR Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibromatose Agressiva / Receptores CXCR Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article